Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

12_07 JS Associates Federal Government Contracting

JS & Associates Federal Government Contracting: Subcontracting - Department Of Treasury Webinar

JS & Associates Federal Government Contracting: Subcontracting - Department Of Treasury Webinar

Summary

Speakers

Liza Craig

Related Content

US Government Moves to Regulate Cross-Border Transactions Involving Sensitive Data

Bigger Fish to Fry: BIS Refines Voluntary Self-Disclosure Process for Minor EAR Violations

CMMC 2.0: Defense Contractors Get Ready

Charlie Brown Finally Kicks the Football: US Outbound Investment Program Will Target China’s Semiconductor, Quantum Computing, and AI Industries

Marking One Year of War, US Broadens Sanctions and Export Controls Against Russia and Other Actors

Sweeping New US Export Controls Target China’s Semiconductor Industry

U.S. Blocks Additional Russian Interests and Restricts Certain Management and Related Services and the Export of Certain Non-Dual Use Items in Latest Actions Against Russia

U.S. Government Authorizes Transactions Related to Patent Protection in Russia

BridgeBio Oncology Therapeutics Completes $200 Million Private Financing

Delphia Therapeutics Completes $67 Million Series A

Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion

Auradine Raises $80 Million in Series B Financing and Achieves $80 Million in Bookings

Cambrian Robotics Closes $3.5 million Seed+ Funding Round

Range Energy Closes on $23.5 Million in New Financing

Goodwin Represents the Initial Purchasers and Dealers on Lyft, Inc.’s $460 million 0.625% Convertible Senior Notes Offering and Capped Call

ARTBIO Collaborates with AlphaGen Therapeutics, and Enters into Three Strategic Agreements to Produce its Lead Asset AB001

Global Trade